| abstract |
Provided herein are compounds and methods for inhibiting histone deacetylase (”HDAC”) enzymes (e.g., HDACl, HDAC2, and HDAC3). The compounds are benzamide derivatives of formula (II) where Het, RA, RB, and RC are as defined herein. The compounds are useful for treating neurological disorders such as Friedreich’s ataxia. |